Barretstown’s Board of Directors and five standing Committees oversee our organisation to ensure transparency and best practice in all areas of the business. All members work on a voluntary basis.

Below please find a list of the current members of each board and committee, and a link to the Terms of Reference for each group.

Board of Directors

Barretstown is headed by a Board of Directors reflecting a mix of public sector, statutory, specialist and fundraising skills. The Board is the governing body, the leader and steward of Barretstown. All Directors act in a voluntary capacity.

  • Mr Maurice Pratt (Chairman) – Chairman, Uniphar Group plc
  • Ms Eimear Burke – Counselling Psychologist
  • Mr Alan Murphy – Managing Partner, Eversheds Sutherland
  • Mr Peter Harding – Chief Operating Officer, Lucozade Ribena Suntory
  • Mr Donagh O’Sullivan – Chief Executive, Galliard Homes
  • Mr Aidan Lynch – Vice President and General Manager, GlaxoSmithKline
  • Dr Jane Pears – Consultant Paediatric Oncologist, Our Lady’s Children’s Hospital, Crumlin
  • Mr John O’ Brien, Managing Director, O’Brien Fine Foods
  • Mr Colm McDonnell, Partner, Risk Advisory, Deloitte

Barretstown Standing Committees

 

Childcare Advisory Committee

  • Dr Jane Pears (Chair) – Board Member, Consultant Paediatric Oncologist, Our Lady’s Children’s Hospital, Crumlin
  • Dr Annemarie Broderick – Consultant Paediatric Gastroenterologist, Our Lady’s Children’s Hospital, Crumlin
  • Ms Annamarie Doody, Senior Social Work Practitioner, Our Lady’s Children’s Hospital, Crumlin
  • Ms Aine Ni Fhaolain – Play Specialist, Our Lady’s Children’s Hospital, Crumlin
  • Ms Eimear Burke – Board Member, Counselling Psychologist
  • Dr Clodagh Ryan – Paediatric Haematologist, Mercy Children’s Hospital, Cork
  • Dr Gemma Kiernan, Chartered Counselling Psychologist and Senior Lecturer in Psychotherapy, School of Nursing and Human Sciences, Dublin City University
  • Ms Orla Keegan – Head of Education Research and Bereavement, The Irish Hospice Foundation
  • Mr Patrick Flanagan – Parent
  • Ms Karen O’ Neill – Past Camper
  • Ms Dee Ahearn – Chief Executive, Barretstown
  • Mr John Fitzgerald – Operations Director, Barretstown
  • Eimear Kinsella, Nursing & Family Liaison Director, Barretstown
  • John Mitchell, Camp Director, Barretstown

Finance & Audit Committee

  • Mr Aidan Lynch (Chair) – Board Member, Vice President and General Manager at GlaxoSmithKline
  • Mr Richard Ball – Chief Investment Officer, Hibernia REIT plc
  • Mr Tom Berrigan, Managing Director, Davy Investment Fund Services
  • Mr Colin Feely, Partner,  Audit & Assurance, Grant Thornton
  • Ms Dee Ahearn – Chief Executive, Barretstown
  • Ms Mairead Forristal – Finance Director, Barretstown

Risk & Governance Committee

  • Mr Alan Murphy (Chair) – Board Member, Managing Partner, Eversheds Sutherland
  • Mr Rory Williams – Chief Legal Advisor, Ervia
  • Ms Dee Ahearn – Chief Executive, Barretstown
  • Ms Mairead Forristal – Finance Director, Barretstown
  • Mr Tim O’Dea – Director of Development, Barretstown

 

Development Committee

  • Mr Maurice Pratt (Chair) – Board Chair, Chairman,Uniphar Group plc
  • Mr Aidan Lynch – Board Member, VP & General Manager, GlaxoSmithKline
  • Mr Peter Harding – Board Member, Chief Operating Officer, Lucozade Ribena Suntory
  • Mr David McKeown – Director, Kilsaran International
  • Mr William Dowling – Director, CBRE
  • Mr John O’Brien – Board Member, Managing Director, O’Brien Fine Foods
  • Ms Aisling Gannon – Partner, Eversheds
  • Mr Andrew Blair – Head of Problem Debt Management, Ulster Bank.
  • Ms Dee Ahearn – Chief Executive, Barretstown
  • Mr Tim O’Dea – Director of Development, Barretstown

Nominations and Remuneration Committee

  • Mr Maurice Pratt (Chair) – Board Chair, Chairman, Uniphar Group plc
  • Mr Alan Murphy – Board Member, Managing Partner, Eversheds Sutherland
  • Mr Rory Williams – Chief Legal Advisor, Ervia
  • Mr Aidan Lynch – Board Member, VP & General Manager, GlaxoSmithKline
  • Ms Dee Ahearn  – Chief Executive, Barretstown *

 

*The CEO is not present for any discussion relating to his/her salary.